Home > Products > Tumor Cell Lines > Human Tumor Cell Lines >
OVTOKO | ||||
---|---|---|---|---|
Product Name | OVTOKO | |||
Price | Get Quote | |||
Cat.No | ABC-TC0888 | Species | Human | |
Size/Quantity | 1 vial | Biosafety Level | 1 | |
Shipping Info | Dry Ice | Storage | Liquid Nitrogen | |
Description | The OVTOKO cell line originates from human ovarian clear cell adenocarcinoma, having been established from metastatic tumors in patients previously subjected to five to six courses of CAP chemotherapy. These cells demonstrate morphological heterogeneity, comprising small to moderately sized cuboidal cells, columnar cells, spindle-shaped cells, and malignant tumor giant cells. They consistently exhibit coexpression of cytokeratins and vimentin, indicative of an epithelial origin in culture, specifically expressing cytokeratin polypeptides 7, 8, 18, and 19. Additionally, OVTOKO cells express epidermal growth factor (EGF) receptors but lack estrogen and progesterone receptors. Notably, intraperitoneal transplantation of OVTOKO cells results in peritoneal implantation and distant metastasis, rendering them a valuable model for investigating ovarian cancer progression and therapeutic strategies.
Why choose OVTOKO from AcceGen? OVTOKO cells from AcceGen exhibit exceptional quality with high viability, ensuring their reliability in research applications. These cells are maintained under stringent sterile conditions, rigorously tested for the absence of bacteria, fungi, and mycoplasma contamination. They are carefully incubated in optimal growth conditions and cryopreserved by skilled operators, guaranteeing their robustness and consistency for various experimental endeavors. | |||
Source Organ | Spleen | |||
Recommended Medium And Supplement | RPMI 1640 + 10% FBS | |||
Citation Guide | When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID). | |||
Application | FOR RESEARCH USE ONLY The OVTOKO cell line serves as a pertinent experimental system, offering a valuable platform for delving into the underlying intrinsic alterations responsible for malignant progression and chemoresistance in ovarian clear cell adenocarcinoma. With its established origins from metastatic tumors in patients who underwent CAP chemotherapy, OVTOKO cells provide researchers with a controlled environment to study the molecular mechanisms and genetic changes contributing to the development of chemoresistance and the progression of this aggressive cancer subtype. This cell line’s unique characteristics make it an indispensable tool for advancing our understanding of ovarian cancer biology and identifying potential therapeutic targets. | |||
Growth Conditions | 37 ℃, 5% CO2 | |||
Product Type | Human Ovarian Cancer Cell Lines | |||
Product Image |
- ONLINE INQUIRY
- PRODUCT REVIEWS
Fill out a request in the form below and we’ll get back to you within 24 hours with a quote.